Xtant Medical names new chief officer: 4 highlights

Written by Mackenzie Garrity | July 10, 2018 | Print  |

Xtant Medical appointed Kevin Brandt as chief commercial officer, effective July 9.

Here are four highlights:

1. Mr. Brandt brings more than 28 years of medical device industry experience into his new role.

2. He formerly served as executive president and CCO for RTI Surgical's domestic direct business.

3. Prior to working at RTI Surgical, Mr. Brant spent 18 years with Stryker.

4. At Stryker, Mr. Brandt served in various leadership positions, including president of osteokinetics for 10 years.

“We are excited to have such a talented and experienced executive officer join our team,” said Carl O’Connell, CEO of Xtant. “[Mr. Brandt's] past accomplishments in the medical device industry show that he is an accomplished business strategist with a unique ability to provide the leadership in sales and marketing to build our Company’s revenues and profitability. I expect his contributions will be transformative for Xtant.”

More articles on devices and implants:
More than just outcomes — Predictive analytics provide support through the surgical continuum
Moving from art to science brings new possibilities to spine surgery
Globus Medical, SeaSpine & more: 5 device company notes

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months